324
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: biomarkers associated with iron and disease status

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2256428 | Received 19 Jun 2023, Accepted 04 Sep 2023, Published online: 12 Sep 2023

Figures & data

Table 1. Demographic and clinical characteristics of the study groups.

Figure 1. Comparison of sRAGE (A), sRANKL (B) and OPG (C) in subgroups of RA patients according to the level of CRP (CRP ≤ 8 and CRP > 8).

Figure 1. Comparison of sRAGE (A), sRANKL (B) and OPG (C) in subgroups of RA patients according to the level of CRP (CRP ≤ 8 and CRP > 8).

Table 2. Correlations of sRAGE in subgroups of RA patients according to the level of CRP (CRP ≤ 8 and CRP > 8).

Table 3. Correlations of sRANKL in subgroups of RA patients according to the level of CRP (CRP ≤ 8 and CRP >8).

Table 4. Correlations of OPG in subgroups of RA patients according to the level of CRP (CRP ≤ 8 and CRP > 8).

Data availability statement

The data that support the findings of this study are available on request from the corresponding author, GD. The data are not publicly available due to their containing information that could compromise the privacy of research participants.